Blood test may let some lymphoma patients stop chemo early
NCT ID NCT06693830
First seen Jan 26, 2026 · Last updated May 15, 2026 · Updated 9 times
Summary
This study is for people newly diagnosed with a type of lymphoma called DLBCL. Researchers want to see if a blood test that tracks tumor DNA can help decide who can safely stop chemotherapy early. About 40 participants will get standard treatment, and those whose blood test shows no cancer halfway through may receive fewer chemo cycles. The goal is to reduce side effects while still controlling the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University
RECRUITINGNew York, New York, 10032, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.